Wright Medical (WMGI)
has long been a challenging med-tech investment story. On the positive
side, the company has been a share gainer in shoulders, still holds a
strong portfolio (and market position) in foot/ankle, and is leveraged
to an underpenetrated market that should support high single-digit
revenue growth for some time to come. On the other hand, sales execution
has been inconsistent at best, and the company is seeing renewed
competitive vigor from rivals like Integra (IART) and Stryker (SYK).
On balance, I still think there’s upside in these shares from here, but management must
execute on a consistent and reliable basis to build real long-term
value for shareholders, and the jury is still out on whether they’re up
to the task.
Click here for more:
Wright Medical Still Walking A Tightrope, But Growth Should Pick Up
No comments:
Post a Comment